Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 51 for:    "Invasive Aspergillosis" | "Anti-Infective Agents"

A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03816176
Recruitment Status : Recruiting
First Posted : January 25, 2019
Last Update Posted : April 9, 2019
Sponsor:
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Global Development, Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2021
  Estimated Study Completion Date : August 2021